跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Enaprinova-10 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Enaprinova-10
Approved
STANDARD
Enaprinova-10
S Kant Healthcare Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e630fa19ee179f96
Company
S Kant Healthcare Ltd.
Type
Standard
Approval Details
Approval Id
e630fa19ee179f96
Drug Approval Philippines Name
Enaprinova-10
Product Name
Enaprinova-10
Registration Number
DRP-15205
Brand Name
Enaprinova-10
Generic Name
Enalapril maleate
Dosage Form
Tablet
Dosage Strength
10 mg
Manufacturer
S Kant Healthcare Ltd.
Importer
Medinova Pharmaceutical Inc.
Distributor
Medinova Pharmaceutical Inc.
Issuance Date
24 May 2024
Expiry Date
24 May 2029
Pharmacologic Category
Angiotensin-converting Enzyme (ACE) Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e630fa19ee179f96
Type
Standard
Back to Philippines FDA Approvals